Using Routine Asymptomatic <i>Clostridioides difficile</i> Testing to Identify Patients at High Risk of Developing <i>Clostridioides difficile</i> Infection During Hematopoietic Cell Transplantation
Pre-admission <i>C. difficile</i> screening could support targeted prophylactic strategies for patients at risk of developing CDI, and this approach warrants further evaluation.
Authors
- Tamara Leite (ORCID: https://orcid.org/0009-0000-1431-8958)
- Derek R. MacFadden (ORCID: https://orcid.org/0000-0002-3838-1211)
- Natasha Kekre (ORCID: https://orcid.org/0000-0001-8394-0855)
- Austin Yan (ORCID: https://orcid.org/0000-0003-4818-9319)
- Leanne Mortimer
- Amanda Carroll (ORCID: https://orcid.org/0000-0001-5941-744X)
- Michael Kennah
- Jean‐François Sénéchal
- Nicole Janusz
- C. Arianne Buchan (ORCID: https://orcid.org/0000-0003-3617-3213)
Institutions
- University of Ottawa (CA)
- Ottawa Hospital (CA)
- Canadian Electricity Association (CA)
- Ottawa Hospital Research Institute (CA)
Publication Details
- Journal
- Journal of the Association of Medical Microbiology and Infectious Disease Canada
- Published
- 2025-09-09
- DOI
- https://doi.org/10.3138/jammi-2024-0032
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Ottawa